Cardiac involvement in progressive systemic sclerosis (P.S.S.)--an echocardiographic study

Area of Science:

• Cardiology
• Rheumatology
• Medical Imaging

Background:

• Progressive systemic sclerosis (scleroderma) can affect multiple organs, including the heart.
• Cardiac involvement in scleroderma may be subclinical, making early detection challenging.

Purpose of the Study:

• To determine the incidence and severity of cardiac lesions in patients with progressive systemic sclerosis using echocardiography.
• To assess the utility of echocardiography in identifying cardiac pathology in scleroderma patients, including those without overt clinical signs.

Main Methods:

• Echocardiography was performed on 20 patients with progressive systemic sclerosis.
• Cardiac findings were systematically recorded and analyzed.
• Electrocardiogram (ECG) changes were also documented.

Main Results:

• Abnormal echocardiographic findings were present in 14 (70%) patients.
• Common findings included pericardial effusion, ventricular dilatation/thickening, and mitral valve abnormalities.
• Clinical evidence of scleroderma heart was noted in only one patient, highlighting a discrepancy with echocardiographic findings.
• Abnormal ECG changes were observed in 12 (60%) patients, including left ventricular hypertrophy and conduction disturbances.

Conclusions:

• Echocardiography is an essential non-invasive diagnostic tool for detecting cardiac lesions in systemic sclerosis patients.
• The study confirms the high prevalence of cardiac pathology, often asymptomatic, in scleroderma.
• Echocardiography effectively bridges the gap between limited clinical signs and extensive cardiac involvement in scleroderma.